Home > Faculty & Staff > Faculty Directory > Olga Geling

Profile

Olga Geling, PhD Assistant Professor, Social & Behavioral Health Sciences 1960 East West Road, Biomed D104A Honolulu, HI 96822 email: geling@hawaii.edu phone: (808) 956-0929 fax: (808) 956-5818

Academic Degrees
PhD (Medical Sociology), University of Illinois Urbana-Champaign
MS (Statistics), University of Illinois Urbana-Champaign

Fellow, Merck & Co., Inc., Outcomes Research, Medical Services, Worldwide Marketing; program jointly with Rutgers University School of Pharmacy

Research Interests (past and current)

Current Research Grants
Evaluation of HIV/AIDS Prevention Programs

Dr. Geling specializes in outcome and process evaluation; developing and measuring outcomes; training; technical assistance with program planning, evaluation, and data; data analysis, interpretation, and presentation; disease management programs; decision analysis; cost-effectiveness/cost-benefit analysis; pharmacoeconomics; epidemiology; and biostatistics. Dr. Geling works extensively with the Hawaii Department of Health (DOH) and other government and non-profit agencies in the State. She is responsible for evaluation of Hawai‘i’s HIV/AIDS prevention programs, in close partnership with the Hawai‘i DOH and community-based organizations (CBOs) across the State.

Selected Publications
Geling O, Eichler HG. Should 5-hydroxytryptamine-3 receptor antagonists be administered beyong 24 hours after chemotherapy to prevent delayed emesis? Systematic re-evaluation of clinical evidence and drug cost implications. Journal of Clinical Oncology Vol. 23, pp1289-1294, 2005.

Sen SS, Rives VP, Messina OD, Morales-Torres J, Riera G, Angulo-Solimano JM, Neto JF, Frisoli A Jr, Saenz RC, Geling O, Ross PD. A risk assessment tool (OsteoRisk) for identifying Latin American women with osteoporosis. Journal of General Internal Medicine Vol. 20, pp. 245-250; 2005.

Eichler HG, Mavros P, Geling O, et al. Association between health-related quality of life and clinical efficacy endpoints in rheumatoid arthritis patients after four weeks of treatment with anti-inflammatory agents. Forthcoming in International Journal of Clinical Pharmacology and Therapeutics.

Grunberg SM, Deuson PR, Mavros P, Geling O, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer Vol. 100, pp. 2261-2268, 2004.

Gallagher TC, Geling O, Comite F. Missed opportunities for prevention of osteoporotic fracture. Archives of Internal Medicine Vol. 162(4), 450-6, 2002.

Koenker R, Geling O. Reappraising medfly longevity: a quantile regression survival analysis. Journal of the American Statistical Association Vol. 96, 458-468, 2001.

Simpson D, Imrey P, Geling O, Butkus S. Statistical estimation of child abuse rates from administrative databases. Children and Youth Services Review, Vol. 22, 951-971, 2000.